\u003c/p>","type":"text"}],"currentPage":0,"pageSize":1},"editorName":"劉暢","editorCode":"PF223","faceUrl":"http://ishare.ifeng.com/mediaShare/home/607286/media","vestAccountDetail":{},"subscribe":{"type":"vampire","cateSource":"","isShowSign":0,"parentid":"0","parentname":"財經","cateid":"607286","catename":"鳳凰網財經","logo":"http://d.ifengimg.com/q100/img1.ugc.ifeng.com/newugc/20171106/10/wemedia/9ff3c57464be746cf440328dfd37fd22b47f17cb_size18_w200_h200.png","description":"鳳凰網財經官方賬號","api":"http://api.3g.ifeng.com/api_wemedia_list?cid=607286","show_link":1,"share_url":"https://share.iclient.ifeng.com/share_zmt_home?tag=home&cid=607286","eAccountId":607286,"status":1,"honorName":"","honorImg":"http://x0.ifengimg.com/cmpp/2020/0907/1a8b50ea7b17cb0size3_w42_h42.png","honorImg_night":"http://x0.ifengimg.com/cmpp/2020/0907/b803b8509474e6asize3_w42_h42.png","forbidFollow":0,"forbidJump":0,"fhtId":"82146729","view":1,"sourceFrom":"","declare":"","originalName":"","redirectTab":"article","authorUrl":"https://ishare.ifeng.com/mediaShare/home/607286/media","newsTime":"2026-03-15 20:32:04","lastArticleAddress":"來自北京市"},"filterMediaList":[{"name":"鳳凰網財經","id":"607286"},{"name":"國際財聞匯","id":"1609082"},{"name":"銀行財眼","id":"1444240"},{"name":"公司研究院","id":"1612328"},{"name":"IPO觀察哨","id":"1601888"},{"name":"風暴眼","id":"1601889"},{"name":"出海研究局","id":"1613468"},{"name":"封面","id":"540061"},{"name":"前行者","id":"1580509"},{"name":"凰家反騙局","id":"1596037"},{"name":"康主編","id":"1535116"},{"name":"啟陽路4號","id":"1021158"},{"name":"財經連環話","id":"7518"}]},"keywords":"企業,醫療健康,專業版,療效,315晚會,騙局","safeLevel":0,"isCloseAlgRec":false,"interact":{"isCloseShare":false,"isCloseLike":false,"isOpenCandle":false,"isOpenpray":false,"isCloseFhhCopyright":false},"hasCopyRight":true,"sourceReason":"","__nd__":"ne883dbn.ifeng.com","__cd__":"c01049em.ifeng.com"};
var adKeys = ["adHead","adBody","topAd","logoAd","topicAd","contentAd","articleBottomAd","infoAd","hardAd","serviceAd","contentBottomAd","commentAd","commentBottomAd","articleAd","videoAd","asideAd1","asideAd2","asideAd3","asideAd4","asideAd5","asideAd6","bottomAd","floatAd1","floatAd2"];
var __apiReport = (Math.random() > 0.99);
var __apiReportMaxCount = 50;
for (var i = 0,len = adKeys.length; i 央視315晚會曝光外泌體騙局,沒有國家批準、沒有通過任何臨床試驗、沒有任何療效數據的所謂“外泌體”,被這些企業包裝成“包治百病”的“神藥”,甚至用“借臺代打”的方式注射進了患者的身體里,而這樁生意,利潤是相當的可觀。 天眼查專業版數據顯示,截至目前我國現存在業、存續狀態的醫療健康相關企業超1047.6萬家。從企業注冊數量趨勢來看,近五年間,醫療健康相關企業的注冊數量呈現出逐年增長的態勢,并在2025年達到頂峰。 天眼查天眼風險顯示,從事醫療健康相關的業務企業中,2.03%的相關企業曾出現法律訴訟,2.64%的相關企業曾出現經營異常,1.18%的相關企業曾出現行政處罰。
萬能神藥外泌體是三無產品,超27.6萬余家醫療健康相關企業出現過經營異常


獨家搶先看